Filing Flows › 8-K events › Pmgc Holdings
Pmgc Holdings: entry into a material definitive agreement
Form 8-K filed Nov 5, 2026 · items 1.01, 7.01
Entry into a material definitive agreementNorthStrive Biosciences Announces Results from EL-32 Preclinical Combination Study with Semaglutide and
What the filing says
On November 1, 2026, PMGC Holdings Inc. (the “Company”), entered into a Consulting Agreement (the “Consulting Agreement”) with IR Agency LLC (the “Consultant”). Under the Consulting Agreement, the Consultant will provide marketing and advertising services to communicate information about the Company to the financial co
Read the filing on SEC EDGAR →
What usually followsAcross 23,525 8-Ks reporting Item 1.01 (material definitive agreement) in our universe, the stock's median move the next session was 0.0% (typical size ±1.4%, up 51% of the time); over the following 21 sessions, +1.0%. Every item ranked →
What this kind of filing means
Item 1.01 — Entry into a material definitive agreement. A material agreement is one the company considers important enough to disclose within four business days: a merger agreement, a large supply or customer contract, a credit agreement or a licence. The terms often move the company’s outlook more than a quarter’s results.
Pmgc Holdings at a glance
Pmgc Holdings, Q2 2026: revenue $1.3M, operating margin -225.1%. The chart follows the revenue to costs, profit and cash.
Pmgc Holdings: every quarter, Q/Q and Y/Y, holders and guidance →
Pmgc Holdings’s other material 8-Ks
Read automatically from SEC EDGAR (13F, Form 4, Form 144, Schedule 13D/G, 8-K, XBRL), House and Senate disclosures, FINRA and exchange data; errors are possible. Not investment advice.